| Literature DB >> 29564404 |
Hassan Hashemi1, Akbar Fotouhi2, Abbasali Yekta3, Reza Pakzad1, Hadi Ostadimoghaddam4, Mehdi Khabazkhoob5.
Abstract
PURPOSE: The aim of the study was a systematic review of refractive errors across the world according to the WHO regions.Entities:
Keywords: Astigmatism; Hyperopia; Meta-analysis; Myopia
Year: 2017 PMID: 29564404 PMCID: PMC5859285 DOI: 10.1016/j.joco.2017.08.009
Source DB: PubMed Journal: J Curr Ophthalmol ISSN: 2452-2325
Search strategy for MEDLINE (MeSH, Medical Subject Headings).
| 1: Refractive errors [Text Word] OR Refractive errors [MeSH Terms] |
| 2: Myopia [Text Word] OR Myopia [MeSH Terms] |
| 3: Hyperopia [Text Word] OR Hyperopia [MeSH Terms] |
| 3: Astigmatism [Text Word] OR Astigmatism [MeSH Terms] |
| 4: Spherical equivalent [Text Word] OR Spherical equivalent [MeSH Terms] |
| 5: Cylinder power [Text Word] OR Cylinder power [MeSH Terms] |
| 6: 1 OR 2 OR 3 OR 4 OR 5 OR 6 |
| 7: Pediatric [Text Word] OR pediatric [MeSH Terms] |
| 8: Children [Text Word] OR children [MeSH Terms] |
| 9: Student [Text Word] OR Student [MeSH Terms] |
| 10: Adolescent[Text Word] OR Adolescent[MeSH Terms] |
| 11: Adult [Text Word] OR Adult [MeSH Terms] |
| 12: 7 OR 8 OR 9 OR 10 OR 11 |
| 13: Prevalence [Text Word] OR Prevalence [MeSH Terms] |
| 14: Frequency [Text Word] OR Frequency [MeSH Terms] |
| 15: Cross-Sectional [Text Word] OR Cross-Sectional [MeSH Terms] |
| 16: Descriptive [Text Word] OR Descriptive [MeSH Terms] |
| 17: Survey [Text Word] OR Survey [MeSH Terms] |
| 18: 13 OR 14 OR 15 OR 16 OR 17 |
| 19: 6 AND 12 AND 18 |
Fig. 1Flow of information through the different phases of the systematic review.
Summary of studies according refractive errors in worldwide.
| Country | Size | Place | Age | Refraction | Myopia | Hyperopia | Astigmatism | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| <−0.5 | ≤−0.5 | ≥2 | >0.5 | ≥0.5 | ≥0.75 | ≥0.5 | |||||
| USA | 11,260 | Los Angeles | 3–5 | Non-cycloplegic | 21% | 58% | |||||
| China | 1839 | Anyang of Henan | 12.9–17.6 | Cycloplegic | 82.7% | 7.5% | |||||
| Norway | 224 | Trondheim | Mean 20.6 | Cycloplegic | 47% | ||||||
| China | 1565 | Inner Mongolia | 6–21 Y | Cycloplegic | 54.1% | 15.5% | |||||
| USA | 4144 | Monterey Park | >50 | Non-cycloplegic | 35.1% | 40.2% | 45.6% | ||||
| Korea | 33,355 | Seoul | ≥5 Y | Non-cycloplegic | 51.9% | 13.4% | |||||
| China | 1415 | Harbin | ≥40 Y | Non-cycloplegic | 38.5% | 19.9% | |||||
| New York | 4709 | New York | 40–84Y | Non-cycloplegic | 21.9% | 46.9% | |||||
| Puerto Rico | 784 | Puerto Rico | ≥40 Y | Non-cycloplegic | 14.7% | 51.5% | |||||
| Netherlands | 520 | Dutch | 11–13 Y | Non-cycloplegic | 28% | 8% | |||||
| Netherlands | 444 | Dutch | 17–60 Y | Non-cycloplegic | 30% | 10% | |||||
| Bangladesh | 11,624 | National | ≥30 Y | Non-cycloplegic | 22.1 | 20.6% | 32.4 | ||||
| India | 1414 | Tamil Nadu | >40 Y | Non-cycloplegic | 19.4% | 39.7% | |||||
| Australia | 148 | Adelaide | 44.8 ± 14.5 Y | Non-cycloplegic | 31.1% | 33.1% | |||||
| India | 11,786 | Hyderabad | ≤15 Y | Cycloplegic | 3.19% | 62.62% | |||||
| India | 3509 | Chennai | >39 Y | Non-cycloplegic | 27% | 18.7% | 54.8% | ||||
| India | 3513 | Chennai | >39 Y | Non-cycloplegic | 16.8% | 52.3% | 53% | ||||
| China | 8398 | Shanghai | 3–10 Y | Cycloplegic | 20.1% | 17.8% | |||||
| California | 1501 NHW | Los Angeles and Riverside | 6–72 M | Cycloplegic | 1.2% | 25.65% | |||||
| California | 1507 Asian | Los Angeles and Riverside | 6–72 M | Cycloplegic | 3.98% | 13.47% | |||||
| California | 2994 | Los Angeles | 6–72 M | Cycloplegic | 20.8% | ||||||
| California | 3030 | Los Angeles | 6–72 M | Cycloplegic | 26.9% | ||||||
| Australia | 1765 | Sydney | 6 | Cycloplegic | 13.2% | ||||||
| Australia | 2353 | Sydney | 12 | Cycloplegic | 5.0% | ||||||
| Brazil | 1032 | Pelotas | 7–15 | Non-cycloplegic | 13.4% | ||||||
| India | 4074 | Hyderabad | 7–15 Y | Cycloplegic | 4.1% | 0.8% | 6.30% | ||||
| China | 5884 | Beijing | 5–15 | Cycloplegic | 14.9% | 2.6% | |||||
| Malaysia | 4634 | Selangor | 7–15 Y | Non-cycloplegic | 20.7% | 21.3% | |||||
| China | 2749 | Anyang | 7.1 Y | Cycloplegic | 3.9% | 23.3% | 25.6 | ||||
| China | 2112 | Anyang | 12.7 Y | Non-cycloplegic | 67.3% | 1.2% | 28.3 | ||||
| India | 1789 | Hyderabad | 7–15 Y | Cycloplegic | 51.4% | 3.3% | |||||
| India | 1525 | Hyderabad | 7–15 Y | Cycloplegic | 16.7% | 3.1% | |||||
| Australia | 1816 | Sydney | 6–72 M | Cycloplegic | 10.5% | 28.9% | |||||
| South Africa | 1939 | Durban | 35–90 Y | Non-cycloplegic | 37.7% | 25.7% | |||||
| Equatorial Guinea | 425 | Malabo | 6–16 Y | Cycloplegic | 10.4% | U(3.1%) | U(32.5%) | ||||
| Rwanda | 634 | Nyarugenge | 11–37 Y | Cycloplegic | 10.2% | 4.3% | 4.4% | ||||
| Ethiopia | 4238 | Butajira | 7–18 Y | Non-cycloplegic | 6.0% | 0.33% | 2.17 | ||||
| Ghana | 2435 | Ashanti region | 12–15 Y | Cycloplegic | 3.2% | 0.3% | |||||
| Kenya | 4414 | Nakuru | ≥50 Y | Non-cycloplegic | 27.4% | ||||||
| Nigeria | 13,599 | Across the country | ≥40 Y | Non-cycloplegic | 16.2% | 50.7% | 63.0% | ||||
| Morocco | 545 | Morocco | 6–16 Y | Cycloplegic | 6.1% | 18.3%. | 23.5% | ||||
| Benin | 1057 | Cotonou | 4–16 Y | Non-cycloplegic | 91.9% | ||||||
| South Africa | 4890 | Durban | 5–15 Y | Cycloplegic | 4.0% | 2.6% | 9.6 | ||||
| Uganda | 623 | Kampala | 6 and 9 | Cycloplegic | 11% | 37% | 52% | ||||
| Ethiopia | 811 | Gondar | 6–16 Y | Non-cycloplegic | 4.8% | 1.6% | 0.4% | ||||
| South Africa | 520 (male) | Durban | 20–75 Y | Non-cycloplegic | 1.9% | 5.8% | |||||
| Ethiopia | 420 | Debre Markos | 7–15 Y | Non-cycloplegic | 5.47% | 1.4% | 1.9% | ||||
| Ethiopia | 1852 | Gondar | 4–24 Y | Non-cycloplegic | 2.3% | 1.3% | |||||
| Brazil | 7654 | Sao Paulo | >1 Y | Cycloplegic | 25.3% | 33.8% | 59.7% | ||||
| Brazil | 2454 | Botucatu | 1–91 Y | Non-cycloplegic | 33.8% | 59.7% | |||||
| Brazil | 1608 | Rio Grande do Sul | 7–10 Y | Non-cycloplegic | |||||||
| Mexico | 317 | Toluca | 6–12 Y | Cycloplegic | 9.7% | 5.4% | |||||
| Brazil | 1024 | Natal | 5–46 Y | Cycloplegic | |||||||
| Chile | 5303 | La Florida | 5–15 Y | Cycloplegic | 5.8%. | 14.5% | 27.2% | ||||
| Wisconsin | 4275 | Beaver Dam | 43–84 Y | Non-cycloplegic | 49.0% | ||||||
| California | 431 | Los Angeles | >55 Y | Non-cycloplegic | 10.4% | 24.8% | 31.8% | ||||
| China | 3070 | Yongchuan | 6–15 Y | Cycloplegic | 13.75% | 3.75% | |||||
| Malaysia | 705 | Kota Bharu | 6–12 Y | Non-cycloplegic | 5.4% | 1.0% | 0.6% | ||||
| Singapore | 946 | Singapore | 15–19 Y | Non-cycloplegic | 73.9% | 1.5% | 58.7% | ||||
| China | 1892 | Xichang | 11.4–17.1 Y | Cycloplegic | 0.2% | 1.7% | |||||
| China | 2480 | Guangzhou | 3–6 Y | Cycloplegic | 2.5% | 20% | |||||
| Nepal | 440 | Kathmandu | 7–15 Y | Cycloplegic | 31.0% | ||||||
| India | Urban: 5021 | Maharashtra | 6–15 | Cycloplegic | 3.16% | 1.06 | 0.16 | ||||
| India | Rural: 7401 | Maharashtra | 6–15 | Cycloplegic | 1.45% | 0.39 | 0.21 | ||||
| Cambodia | 5527 | Phnom Penh | 12–14 Y | Cycloplegic | 5.8% | 0.7% | 3.76% | ||||
| Singapore | 1232 | Tanjong Pagar district | 40–79 Y | Non-cycloplegic | 38.7% | 28.4% | |||||
| Myanmar | 2076 | Meiktila district | ≥40 Y | Non-cycloplegic | |||||||
| Indonesia | 1043 | Sumatra | ≥21 Y | Non-cycloplegic | 13.9% | ||||||
| Japan | 3021 | Tajimi | >40 Y | Non-cycloplegic | 51% | 27.9% | |||||
| India | 2522 | Andhra Pradesh | 40–92 Y | Non-cycloplegic | 18.4% | ||||||
| South Korea | 22,562 | Knhanes | >20 Y | Non-cycloplegic | 41.8% | 24.2 | |||||
| South Korea | 1079 | Jeolla | 8–13 Y | Non-cycloplegic | 46.5% | 6.2% | |||||
| China | 2255 | Xuzhou | 24–80 M | Cycloplegic | 48.1 | ||||||
| Vietnam | 2238 | Ba Ria – Vung Tau | 12–15 Y | Cycloplegic | 20.4% | 0.4% | 0.7% | ||||
| China | 1675 | Heilongjiang | 5–18 Y | Cycloplegic | 5.0% | 1.6% | |||||
| South Korea | 1532 | Namil-myeon | ≥40 Y | Non-cycloplegic | 41.8% | ||||||
| Nepal | 2000 | Kathmandu | 5–16Y | Cycloplegic | 6.85 | ||||||
| India | 4711 | Not-available | 30–100 Y | Non-cycloplegic | 20.5% | 18.0& | |||||
| Laos | 2899 | Vientiane | 6–11 Y | Cycloplegic | 0.8% | 2.8% | 9% | ||||
| China, | 2422 | Bai nationality | 6–15 Y | Non-cycloplegic | 38.1% | 22.8% | |||||
| Singapore | 2804 | Southeast district of Singapore | 55–89 Y | Non-cycloplegic | 30.1 | 41.5 | |||||
| Singapore | 2805 | Southwestern Singapore | Over 40 Y | Non-cycloplegic | 22.8% | 35.9% | |||||
| Thailand | 1100 | Bangkok and Nakhonpathom | 6–12 Y | Cycloplegic | 11.1% | 1.4% | 0.3% | ||||
| China | 4979 | Harbin | ≥50 Y | Non-cycloplegic | 28.0% | 8.9% | |||||
| Singapore | 2974 | Malay | 40–80 Y | Non-cycloplegic | 27.4% | ||||||
| China | 4364 | Guangzhou | 5–15 Y | cycloplegic | 9.5% | 5.8% | 33.6% | ||||
| China | 2256 | Lanzhou | 15–19 Y | Non-cycloplegic | 35.1% | 0.2% | 40.8% | ||||
| China | 4439 | Beijing | >40 Y | Cycloplegic | 62.3% | 19.5% | |||||
| China | 2515 | Yangxi | 13–17 Y | Cycloplegic | 86.5% | 1.20% | 25.3% | ||||
| India | 1062 | Kanchipuram | 6–16 Y | Cycloplegic | 21.4% | 0.56 | |||||
| India | 2508 | Tamil Nadu | >39 Y | Non-cycloplegic | 42.4% | 18.70% | |||||
| India | 6447 | New Delhi | 5–15 Y | Cycloplegic | 7.4% | 7.7% | 10.19% | ||||
| Nepal | 5067 | Mechi zone | 5–15 Y | Cycloplegic | 1.2% | 2.1% | 3.5% | ||||
| Poland | 5724 | Szczecin | 6–18 Y | Cycloplegic | 13% | 4.0% | |||||
| Poland | 4422 | Szczecin | 6–18 Y | Cycloplegic | 13.3% | ||||||
| Sweden | 143 | Gothenburg | 4–15 | Cycloplegic | 6% | 9% | 22% | ||||
| England | 2495 | Not available | 44–46 Y | Non-cycloplegic | 47.8 | 8.8 | |||||
| England | 7444 | Not available | 48–92 Y | Non-cycloplegic | 23 | 39.4 | |||||
| Norway | 5792 | Not available | 38–87 Y | Non-cycloplegic | 19.4 | 33.7 | |||||
| Greece | 1952 | Not available | 60–94 Y | Non-cycloplegic | 14.2 | 39.4 | |||||
| France | 618 | Not available | 73–93 Y | Non-cycloplegic | 16.7 | 53.6 | |||||
| Netherlands | 2662 | Not available | 14–87 Y | Non-cycloplegic | 21.2 | 27.4 | |||||
| Germany | 14,069 | Not available | 35–74 Y | Non-cycloplegic | 31.9 | 23.9 | |||||
| France | 576 | Not available | 76–92 Y | Non-cycloplegic | 19.1 | 51.1 | |||||
| France | 2315 | Not available | 60–93 Y | Non-cycloplegic | 16.2 | 53 | |||||
| Netherlands | 6566 | Not available | 55–106 Y | Non-cycloplegic | 16.4 | 52.3 | |||||
| Netherlands | 2579 | Not available | 55–99 Y | Non-cycloplegic | 21.9 | 45.7 | |||||
| Netherlands | 3530 | Not available | 46–97 Y | Non-cycloplegic | 32.5 | 28.8 | |||||
| UK | 6095 | Not available | 16–85 Y | Non-cycloplegic | 31.4 | 26 | |||||
| Germany | 2372 | Not available | 35–84 Y | Non-cycloplegic | 36.1 | 24 | |||||
| England | 4488 | Not available | 48–89 Y | Non-cycloplegic | 27.8% | 49.4% | |||||
| Germany | 13,959 | Gutenberg | 35–74 Y | Non-cycloplegic | 35.1 | 31.8% | 32.3 | ||||
| Spain | 417 | Segovia | 40–79 Y | Non-cycloplegic | 25.4% | 43.6% | 53.5 | ||||
| Greece | 1500 | Athens | 40–77 Y | Non-cycloplegic | 35.1% | 14.40% | |||||
| Sweden | 1045 | Goteborg | 12–13 Y | cycloplegic | 49.7% | ||||||
| Turkey | 21,062 | Diyarbakir | 6–14 Y | Cycloplegic | 3.2% | 14.3% | |||||
| Pakistan | 45,122 | Rawalpindi | 5–16 Y | Cycloplegic | 1.89% | 0.76% | |||||
| Turkey | 709 | Eskisehir | 7–8 Y | cycloplegic | 22.6% | 11.0% | |||||
| Iran | 1367 | Mashhad | >54 | Non-cycloplegic | 27.2% | 51.6% | 37.5% | ||||
| Iran | 1854 | Shiraz | 7–15 | Cycloplegic | 4.35% | 5.04% | 11.27% | ||||
| Iran | 201 | Khaf | 19–90 | Non-cycloplegic | 28 | 19.2% | 14.3% | ||||
| Iran | 1551 | Bojnord | 6–17 | Cycloplegic | 4.3% | 5.4% | 11.5% | ||||
| Iran | 937 | Sari | 55–87 | Non-cycloplegic | 39.5% | ||||||
| Iran | 2098 | Yazd | 40–80 | Non-cycloplegic | 36.5 | 20.6% | 53.8 | ||||
| Jordan | 1647 | Tafila | 12–17 Y | Non-cycloplegic | 63.5% | 11.2% | |||||
| Jordan | 1093 | Amman | 17–40 Y | Non-cycloplegic | 36.3% | 5.67% | 36.8% | ||||
| Saudi Arabia | 1319 | Riyadh | 4–6 Y | Non-cycloplegic | 2.1% | ||||||
| Saudi Arabia | 1536 | Riyadh | 12–13 Y | Non-cycloplegic | 53.71% | ||||||
| Pakistan | 917 | Khyber Pakhtunkhwa | >30 Y | Non-cycloplegic | 2.5% | ||||||
| Iran | 4072 | 8 Cities | 7 Y | Cycloplegic | 4.5% | 3.04% | 6.20% | ||||
| Pakistan | 1644 | Kohat | 5–15 Y | Non-cycloplegic | |||||||
| Iran | 2410 | Tehran | 7–12 Y | Cycloplegic | 4.9% | 3.5% | 22.6% | ||||
| Iran | 1109 | Dezful | 6–15 Y | Cycloplegic | 3.4% | 12.9% | |||||
| Iran | 3675 | Mashhad | 4–6 Y | Non-cycloplegic | |||||||
| Pakistan | 300 | Haripur | 5–20 Y | Cycloplegic | 14.9% | 52.6% | 28.4% | ||||
| Pakistan | 533 | Lahore | 9–18 Y | Non-cycloplegic | |||||||
| Iran | 2124 | Khaf | 16–65 Y | Non-cycloplegic | |||||||
| Iran | 434 | Aligoudarz | 14–21 Y | Non-cycloplegic | 29.3% | 21.7% | |||||
| Iran | 1431 | Mashhad | 18–32 Y | Non-cycloplegic | 7.8% | ||||||
| Iran | 5020 | Shahroud | 40–64 Y | Non-cycloplegic | |||||||
| Iran | 2048 | Mashhad | >15 Y | Non-cycloplegic | 22.36% | 34.21% | 25.64% | ||||
| Iran | 765 | Mashhad | ≤15 Y | Cycloplegic | 3.64% | 27.4% | |||||
| Iran | 5903 | Qazvin | 7–15 Y | Cycloplegic | 65%, | 12.46% | 16.1% | ||||
| China | 1269 | Liwan | ≥50 Y | Subjective | 32.3% | 40.0% | |||||
| Pakistan | 14,490 | Nationally | >30 Y | Non-cycloplegic | 27.1% | ||||||
| Iran | 5544 | Dezful | 7–15 Y | Cycloplegic | 3.4% | 16.6% | 18.7% | ||||
| Pakistan | 2317 | Kolkata | 5–10 Y | Non-cycloplegic | 36.5% | ||||||
| Australia | 1936 | Sydney | 4–12 Y | Non-cycloplegic | 14.02% | 8.4% | 38.4% | ||||
| Australia | 2535 | Sydney | 4–12 Y | Non-cycloplegic | 3.8% | 6.5% | 39.25% | ||||
| Australia | 3654 | Sydney | 49–97 Y | Non-cycloplegic | 57% | 37% | |||||
| Singapore | 10,033 | Singapore | >40 Y | Non-cycloplegic | 38.9% | 31.5% | |||||
| Iran | 4864 | Shahroud | 40–65 Y | Cycloplegic | 30.2 | 35.6 | |||||
| Argentina | 1518 | Buenos Aires | 25–65 Y | Non-cycloplegic | 18.1% | ||||||
| China | 6491 | Handan | ≥30 Y | Non-cycloplegic | 15.9% | ||||||
| Iran | 4354 | Tehran | ≥5 Y | Non-cycloplegic | 21.8% | 26% | 29.6% | ||||
| Iran | 4354 | Tehran | ≥5 Y | Cycloplegic | 17.2% | 56.6% | 30.3% | ||||
| China | 4319 | Beijing | 40–90 Y | Non-cycloplegic | 20% | ||||||
| Taiwan | 2045 | Taipei | ≥65 Y | Non-cycloplegic | 19.4% | 59% | |||||
| China | 6491 | Handan | 40–79 Y | Non-cycloplegic | 22.9% | 1.6% | |||||
| Mongolia | 1617 | Hövsgöl and Omnögobi | ≥40 Y | Non-cycloplegic | 19.4% | 32.9% | |||||
| Australia | 4744 | Victoria | ≥40 Y | Non-cycloplegic | 19.4% | 18% | |||||
| India | 5885 | Central Maharashtra | ≥30 Y | Non-cycloplegic | 17.2% | 18% | |||||
| Australia | 1884 | Central Australia | >20 Y | Non-cycloplegic | 17% | ||||||
| Norfolk Island | 677 | Norfolk Island | ≥15 Y | Non-cycloplegic | 17% | ||||||
| Maryland | 6000 | 10 Cities | 45–84 Y | Non-cycloplegic | 11.1% | ||||||
| Iran | 815 | Shahrood | 6 Y | Cycloplegic | 20.5% | 1.7% | |||||
| Mongolia | 1057 | Khovd | 7–17 Y | Non-cycloplegic | |||||||
| India | 1378 | Bangalore | 7–15 Y | Cycloplegic | 4.4% | ||||||
| Mexico | 1035 | Monterrey | 12–13 Y | Cycloplegic | 44% | ||||||
| Iran | 3490 | Dezful | 7–15 | Cycloplegic | 3.4% | 16.6 | 18.7 | ||||
Y: Year, M: Month.
Spherical equivalent (SE) worse than >0.75 diopter (D).
Estimated pool prevalence (EPP) of myopia, hyperopia, and astigmatism in children and adult by WHO regions.
| Astigmatism | Astigmatism | Hyperopia | Myopia |
|---|---|---|---|
| %EPP(95%CI); weight | %EPP(95%CI); weight | %EPP(95%CI); weight | |
| Children | |||
| Africa | 14.2 (9.9–18.5); 10.33 | 3.0 (1.8–4.3); 10.57 | 6.2 (4.8–7.6); 16.48 |
| Americas | 27.2 (26–28.4); 2.11 | 14.3 (13.4–15.2); 4.14 | 8.4 (4.9–12); 6.09 |
| South-East Asia | 9.8 (6.3–13.2); 16.47 | 2.2 (1.2–3.3); 20.89 | 4.9 (1.6–8.1); 8.52 |
| Europe | 12.9 (4.1–21.8); 6 | 9 (4.3–13.7); 1.04 | 14.3 (10.5–18.2); 16.04 |
| Eastern Mediterranean | 20.4 (14.5–26.3); 29.11 | 6.8 (4.9–8.6); 30.75 | 9.2 (8.1–10.4); 26.69 |
| Western Pacific | 12.1 (8.4–15.8); 35.98 | 3.1 (1.9–4.3); 32.59 | 18.2 (10.9–25.5); 26.18 |
| All | 14.9 (12.7–17.1); 100 | 4.6 (3.9–5.2); 100 | 11.7 (10.5–13.0); 100 |
| Adult | |||
| Africa | 11.4 (2.1–20.7); 8.85 | 38.6 (22.4–54.8); 6.54 | 16.2 (15.6–16.8); 2.01 |
| Americas | 45.6 (44.1–47.1); 2.95 | 37.2 (25.3–49); 13.05 | 22 (16.4–27.7); 7.98 |
| South-East Asia | 44.8 (36.6–53.1); 17.58 | 28 (23.4–32.7); 21.79 | 32.9 (25.1–40.7); 18.02 |
| Europe | 39.7 (34.5–44.9); 8.82 | 23.1 (6.1–40.2); 4.36 | 27 (22.4–31.6); 29.99 |
| Eastern Mediterranean | 41.9 (33.6–50.2); 29.39 | 33 (26.9–39); 19.54 | 24.1 (14.2–34); 13.98 |
| Western Pacific | 44.2 (30.6–57.7); 32.41 | 28.5 (20.1–37); 34.73 | 25 (20–30.1); 28.01 |
| All | 40.4 (34.3–46.6); 100 | 30.9 (26.2–35.6); 100 | 26.5 (23.4–29.6); 100 |
EPP: Estimated pool prevalence.
CI: Confidence interval.
Fig. 2Forest plot of estimated pool prevalence (EPP) of myopia [spherical equivalent (SE) ≤ −0.5] in children by WHO regions.
Fig. 3Forest plot of estimated pool prevalence (EPP) of myopia [spherical equivalent (SE) ≤ −0.5] in adults by WHO regions.
Fig. 4Trend of myopia from 1990 to 2016.
Fig. 5Forest plot of estimated pool prevalence (EPP) of hyperopia [spherical equivalent (SE) ≥ +2] in children by WHO regions.
Fig. 6Forest plot of estimated pool prevalence (EPP) of hyperopia [spherical equivalent (SE) > +0.5] in adults by WHO regions.
Fig. 7Trend of hyperopia from 1990 to 2016.
Fig. 8Forest plot of estimated pool prevalence (EPP) of astigmatism (cylinder power >0.5) in children by WHO regions.
Fig. 9Forest plot of estimated pool prevalence (EPP) of astigmatism (cylinder power >0.5) in adults by WHO regions.